Neola Medical AB (publ) (NEOLA) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to today's webcast with Neola Medical where CEO Hanna Sjöström and CFO David Folkesson will present the third quarter of 2024. After the presentation there will be a Q&A so if you have any questions for Neola you can submit them via the form to the right. And with that said I hand over the word to you Hanna. Well, thank you so much and a very warm welcome to everyone. Today, we will present Neola Medical's Q3 report of 2024, and we're really excited to summarize an intensive and productive first three quarters. and we are continuing to reach the milestones according to our business strategy. This is a special quarter for us because this is where we have advanced to clinical validation phase where we're really intensifying our preparations for the very first pivotal clinical study on preterm born babies that we're going to do in the US next year. And that will really be a cornerstone in our forthcoming FDA application, securing market approval for our medical device, Niola. Presenting here today is myself, Hanna Syström, CEO at Neola Medical and CFO, David Folkesson. So first I will focus on presenting the company a bit to give you a flavor of what Neola Medical is, our key strategies and our business plan moving forward. And then I'll talk about the quarter and significant events. And thereafter, David will walk you through the numbers and our financial summary. And before we begin, please note that this presentation includes forward-looking statements based on the current expectations and assumptions. These involve risks and uncertainties and may cause actual results to differ. So key factors might include market conditions, regulatory changes, and execution of strategies. But our focus remains on driving sustainable growth and delivering long-term...